Plain-English translation of NCT05343169 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a community-based support program designed specifically for military veterans struggling with opioid use. The program uses peer outreach workers—people with lived experience—to provide overdose education, teach about life-saving medications like naloxone, and help connect veterans to treatment and social services. The goal is to reduce overdose deaths, HIV infections, and other harms related to opioid use.
Military veterans are dying from opioid overdoses at alarming rates, and many veterans—especially those without VA benefits or with difficult discharge statuses—feel isolated and avoid seeking help. This treatment aims to bridge that gap by meeting veterans where they are with trusted peer support, rather than waiting for them to seek care on their own.
If you are selected for the support group, peer workers will meet with you regularly over 9 months to teach you about overdose prevention, provide naloxone (a life-saving overdose reversal medication), and help you navigate treatment options, housing, employment, and other services you may need. The comparison group will receive overdose education and naloxone plus referrals to treatment, but without the ongoing peer support. The trial is currently not enrolling new participants.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
New York University
Enrollment target
~300 participants
Started
October 2022
Primary completion
June 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.